New Hope for Sickle Cell Disease: Groundbreakin...

July 19, 2023

The Institute for Clinical and Economic Review (ICER) has released an updated Evidence Report assessing the potential impact of two revolutionary gene therapies for sickle cell disease (SCD) - exagamglogene autotemc...

When you collaborate with VSH Foundation, it's like unlocking a new dimension in healthcare innovation.

Our research synergizes with your vision, combining expertise in health economics, policy analysis, advanced analytics, and AI applications in healthcare. You’ll witness the fusion of cutting-edge methodologies and real- world impact, as we work together to transform healthcare systems and improve patient outcomes globally.

CORRESPONDENCE ADDRESS

PO Box 8547, #95478, Boston, MA 02114, USA

© 2024 Value Science Health Foundation. All rights reserved.
Made with by Frogiez